Skip to main content

Articles

3909 result(s) for 'lung cancer prognosis stage 4' within BMC Cancer

Page 1 of 79

  1. A frequent manifestation of advanced lung cancer is malnutrition, timely identification and treatment of which can lead to improved patient outcomes. Bioelectrical impedance analysis (BIA) is an easy-to-use an...

    Authors: Digant Gupta, Carolyn A Lammersfeld, Pankaj G Vashi, Jessica King, Sadie L Dahlk, James F Grutsch and Christopher G Lis
    Citation: BMC Cancer 2009 9:37
    Content type: Research article Published on:

  2. Lung cancer is one of the leading causes of cancer death worldwide. Even with complete resection, the prognosis of early-stage non-small cell lung cancer is poor due to local and distant recurrence, and it rem...

    Authors: Hiroshi Kubo, Takashi Suzuki, Tomoko Matsushima, Hideki Ishihara, Kazuya Uchino, Satoshi Suzuki, Sachiyo Tada, Masahiro Yoshimura and Takashi Kondo
    Citation: BMC Cancer 2014 14:755
    Content type: Research article Published on:

  3. The prognosis of SCLC is poor and difficult to predict. The aim of this study was to explore whether a model based on radiomics and clinical features could predict the prognosis of patients with limited-stage ...

    Authors: Jiehan Wu, Yuntao Zhou, Chang Xu, Chengwen Yang, Bingxin Liu, Lujun Zhao, Jiawei Song, Wei Wang, Yining Yang and Ningbo Liu
    Citation: BMC Cancer 2024 24:170
    Content type: Research Published on:

  5. 18 F-FDG is a glucose analogue whose metabolic index SUV can effectively reflect the metabolic level of tumor microenvironment. Aspirin can affect the uptake of 18F-FDG by cancer cells, reducing the SUVmax val...

    Authors: Jinghua Chen, Junxian Xia, Jiacheng Huang and Ruilian Xu
    Citation: BMC Cancer 2020 20:510
    Content type: Research article Published on:

  6. The prognosis of patients with lung cancer who demonstrate pleural plaques intraoperatively, which may be associated with exposure to asbestos, is unclear. Here, we compared the clinicopathological characteris...

    Authors: Atsushi Kagimoto, Takeshi Mimura, Atsushi Kamigaichi and Yoshinori Yamashita
    Citation: BMC Cancer 2022 22:469
    Content type: Research Published on:

  7. Serum cholinesterase (ChE) was found to be involved in cancer initiation and progression. However, the survival association between serum ChE and non-small cell lung cancer (NSCLC) has not been extensively dis...

    Authors: Hailiang Ran, Jie Ma, Le Cai, Hai Zhou, Zhongqin Yuan, Ying Chen, Wei Chang, Yunchao Huang and Yuanyuan Xiao
    Citation: BMC Cancer 2022 22:93
    Content type: Research Published on:

  8. The majority of lung cancer(LC) patients are diagnosed at advanced stage with a poor prognosis. However, there is still no ideal diagnostic and prognostic prediction model for lung cancer.

    Authors: Jingmin Yuan, Yan Sun, Ke Wang, Zhiyi Wang, Duo Li, Meng Fan, Xiang Bu, Jun Chen, Zhiquan Wu, Hui Geng, Jiamei Wu, Ying Xu, Mingwei Chen and Hui Ren
    Citation: BMC Cancer 2022 22:686
    Content type: Research Published on:

  10. Disorders of cell adhesion are critical steps in cancer progression in which varieties of markers including cadherins are involved in.Btbd7 was found to inhibit E-cadherin expression in MDCK cells and play imp...

    Authors: Chuifeng Fan, Yuan Miao, Xiupeng Zhang, Di Liu, Guiyang Jiang, Xuyong Lin, Qiang Han, Lan Luan, Zhonghai Xu and Enhua Wang
    Citation: BMC Cancer 2014 14:704
    Content type: Research article Published on:

  11. Numerous studies have demonstrated that the high-order features (HOFs) of blood test data can be used to predict the prognosis of patients with different types of cancer. Although the majority of blood HOFs ca...

    Authors: Liping Luo, Yubo Tan, Shixuan Zhao, Man Yang, Yurou Che, Kezhen Li, Jieke Liu, Huaichao Luo, Wenjun Jiang, Yongjie Li and Weidong Wang
    Citation: BMC Cancer 2023 23:496
    Content type: Research Published on:

  12. KRAS mutations are common in colorectal cancer (CRC). The role of KRAS mutation status as a prognostic factor remains controversial, and most large population-based cohorts usually consist of patients with non-me...

    Authors: Hae Su Kim, Jin Seok Heo, Jeeyun Lee, Ji Yun Lee, Min-Young Lee, Sung Hee Lim, Woo Yong Lee, Seok Hyung Kim, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Seung Tae Kim, Joon Oh Park, Ho Yeong Lim, Yong Soo Choi, Woo Il Kwon…
    Citation: BMC Cancer 2016 16:120
    Content type: Research article Published on:

  13. As a negative modulator of the canonical Wnt signaling pathway, Naked1 (NKD1) is widely expressed in many normal tissues. However, the expression pattern and clinicopathological significance of NKD1 in patient...

    Authors: Sheng Zhang, Yan Wang, Shun-Dong Dai and En-Hua Wang
    Citation: BMC Cancer 2011 11:186
    Content type: Research article Published on:

  14. Ribosomal protein S6 (S6), a downstream effect media of the AKT/mTOR pathway, not only is a part of 40S small subunit of eukaryotic ribosome, but also involves in protein synthesis and cell proliferation durin...

    Authors: Yaoxiang Tang, Jiadi Luo, Ying Zhou, Hongjing Zang, Yang Yang, Sile Liu, Hongmei Zheng, Jian Ma, Songqing Fan and Qiuyuan Wen
    Citation: BMC Cancer 2022 22:564
    Content type: Research Published on:

  15. As segmentectomy had become commonly used for Non-Small Cell Lung Cancer (NSCLC) treatment, which had the advantages of radical operation, however, it remains controversial owing to procedural complexity and r...

    Authors: Yaodong Zhou, Tao Yu, Yixin Zhang, Liqiang Qian and Qing Xia
    Citation: BMC Cancer 2022 22:71
    Content type: Research Published on:

  17. An increasing number of small nucleolar RNA host genes (SNHGs) have been revealed to be dysregulated in lung cancer tissues, and abnormal expression of SNHGs is significantly correlated with the prognosis of l...

    Authors: Guo-yi Shen, Rong-zhi Huang, Shao-bin Yang, Rong-qiang Shen, Jian-li Gao and Yi Zhang
    Citation: BMC Cancer 2023 23:1243
    Content type: Research Published on:

  18. Lung cancer is among the major diseases threatening human health. Although the immune response plays an important role in tumor development, its exact mechanisms are unclear.

    Authors: Shaodi Wen, Weiwei Peng, Yuzhong Chen, Xiaoyue Du, Jingwei Xia, Bo Shen and Guoren Zhou
    Citation: BMC Cancer 2022 22:193
    Content type: Research Published on:

  20. Lung cancer is the major malignant tumour. The present study was conducted to determine the expression level of syntenin in lung cancer tissues and serum from lung cancer patients and to explore its clinical s...

    Authors: Pengyong Luo, Xuli Yang, Shiren Huang, Shu Feng and Zongxing Ou
    Citation: BMC Cancer 2020 20:159
    Content type: Research article Published on:

  21. To investigate the prognostic value of oligo-recurrence in patients with brain-only oligometastases of non-small cell lung cancer (NSCLC) treated with stereotactic radiosurgery (SRS) or stereotactic radiothera...

    Authors: Yuzuru Niibe, Tetsuo Nishimura, Tetsuya Inoue, Katsuyuki Karasawa, Yoshiyuki Shioyama, Keiichi Jingu and Hiroki Shirato
    Citation: BMC Cancer 2016 16:659
    Content type: Research article Published on:

  22. Kaiso has been identified as a new member of the POZ-zinc finger family of transcription factors that are implicated in development and cancer. Although controversy still exists, Kaiso is supposed to be involv...

    Authors: Shun-Dong Dai, Yan Wang, Yuan Miao, Yue Zhao, Yong Zhang, Gui-Yang Jiang, Peng-Xin Zhang, Zhi-Qiang Yang and En-Hua Wang
    Citation: BMC Cancer 2009 9:178
    Content type: Research article Published on:

  23. The relapse rate in early stage non-small cell lung cancer (NSCLC) after surgical resection is high. Prognostic biomarkers may help identify patients who may benefit from additional therapy. The Helicase-like ...

    Authors: Ludovic Dhont, Melania Pintilie, Ethan Kaufman, Roya Navab, Shirley Tam, Arsène Burny, Frances Shepherd, Alexandra Belayew, Ming-Sound Tsao and Céline Mascaux
    Citation: BMC Cancer 2018 18:429
    Content type: Research article Published on:

  24. Immunotherapy is becoming a standard of care for non-small cell lung cancer (NSCLC). Checkpoint inhibitor-associated pneumonia (CIP) is a rare and potentially life-threatening event that can occur at any time ...

    Authors: Aiben Huang, Yang Xu, Xuelei Zang, Chongchong Wu, Jie Gao, Xiaoli Sun, Mei Xie, Xidong Ma, Hui Deng, Jialin Song, Fangping Ren, Li Pang, Jin Qian, Zhaofeng Yu, Shiyu Wan, Yuanyuan Chen…
    Citation: BMC Cancer 2021 21:634
    Content type: Research Published on:

  25. This study aimed to systematically analyze the effect of a serine/threonine kinase (STK11) mutation (STK11mut) on therapeutic efficacy and prognosis in patients with non-small cell lung cancer (NSCLC).

    Authors: Ke Xu, Weinan Lu, Airu Yu, Hongwei Wu and Jie He
    Citation: BMC Cancer 2024 24:491
    Content type: Research Published on:

  26. Accumulating evidence indicates that long non-coding RNAs (lncRNAs) are involving in the tumorigenesis and metastasis of lung cancer. The aim of the study is to systematically characterize the lncRNA-associate...

    Authors: Yuan Xu, Guofu Lin, Yifei Liu, Xianbin Lin, Hai Lin, Zhifeng Guo, Yingxuan Xu, Qinhui Lin, Shaohua Chen, Jiansheng Yang and Yiming Zeng
    Citation: BMC Cancer 2022 22:188
    Content type: Research Published on:

  27. Progressive lung cancer is associated with abnormal coagulation. Platelets play a vital part in evading immune surveillance and angiogenesis in the case of tumor metastasis. The study aimed to analyze the pred...

    Authors: Lu Xu, Fangzhou Xu, Haobo Kong, Meiling Zhao, Yuanzi Ye and Yanbei Zhang
    Citation: BMC Cancer 2020 20:1152
    Content type: Research article Published on:

  28. The identification of cancer-associated long non-coding RNAs and the investigation of their molecular and biological functions are important for understanding the molecular biology and progression of cancer. H...

    Authors: Xiang-hua Liu, Zhi-li Liu, Ming Sun, Jing Liu, Zhao-xia Wang and Wei De
    Citation: BMC Cancer 2013 13:464
    Content type: Research article Published on:

  29. Epidermal growth factor receptor (EGFR) amplification refers to the copy number increase of EGFR gene, and is often identified as a “bypass” way of Epidermal growth factor receptor Tyrosine kinase inhibitors (...

    Authors: Duanyang Peng, Pingan Liang, Congying Zhong, Peng Xu, Yanqing He, Yuxi Luo, Xia Wang, Anwen Liu and Zhimin Zeng
    Citation: BMC Cancer 2022 22:1323
    Content type: Research Published on:

  30. SET domain containing 5 (SETD5) is related to the aggressiveness of prostate and mammary cancers, but its association with non-small cell lung cancer (NSCLC) is unknown. Therefore, the purpose of this research...

    Authors: Hairu Yu, Jiayi Sun, Congxuan Zhao, Haotian Wang, Yeqiu Liu, Jiajia Xiong, Jing Chang, Mixue Wang, Wenhui Wang, Dongman Ye, Hongyan Zhou and Tao Yu
    Citation: BMC Cancer 2019 19:736
    Content type: Research article Published on:

  31. High-level expression of NAD(P)H: quinoneoxidoreductase 1 (NQO1) has been correlated with many types of human cancers, suggesting that NQO1 plays important roles in tumor occurrence and progression. This study...

    Authors: Zhenling Li, Yue Zhang, Tiefeng Jin, Jiguang Men, Zhenhua Lin, Peng Qi, Yingshi Piao and Guanghai Yan
    Citation: BMC Cancer 2015 15:207
    Content type: Research article Published on:

  32. According to the literature and our experience, the most common sites of non-small cell lung cancer (NSCLC) metastases include the brain, bone, liver, adrenal glands, contralateral lung and distant lymph nodes...

    Authors: Fei-Yu Niu, Qing Zhou, Jin-Ji Yang, Wen-Zhao Zhong, Zhi-Hong Chen, Wei Deng, Yan-Yan He, Hua-Jun Chen, Zhu Zeng, E-E Ke, Ning Zhao, Na Zhang, Hui-Wen Sun, Qiu-Yi Zhang, Zhi Xie, Xu-Chao Zhang…
    Citation: BMC Cancer 2016 16:149
    Content type: Research article Published on:

  33. This study aimed to construct a nomogram to effectively predict the overall survival (OS) of patients with early-stage non-small-cell lung cancer (NSCLC).

    Authors: Liang Zhou, Yahui Zhang, Wenyu Chen, Niu Niu, Junjie Zhao, Weibo Qi and Yufen Xu
    Citation: BMC Cancer 2022 22:980
    Content type: Research Published on:

  34. Lung immune prognostic index (LIPI) is a prognostic marker of extensive-stage small cell lung cancer (ES-SCLC) patients received immunotherapy or chemotherapy. However, its ability in limited-stage SCLC (LS-SC...

    Authors: Bochen Sun, Qing Hou, Yu Liang, Shuqin Xue, Ningning Yao, Lijuan Wei, Xin Cao, Hongwei Li, Hongwei Si and Jianzhong Cao
    Citation: BMC Cancer 2022 22:1233
    Content type: Research Published on:

  35. Lung squamous cell carcinoma (LUSC) is prone to metastasis and likely to develop resistance to chemotherapeutic drugs. DNA repair has been reported to be involved in the progression and chemoresistance of LUSC...

    Authors: Xinshu Wang, Zhiyuan Huang, Lei Li, Guangxue Wang, Lin Dong, Qinchuan Li, Jian Yuan and Yunhui Li
    Citation: BMC Cancer 2022 22:866
    Content type: Research Published on:

  36. Recently, a growing number of studies have reported the coorelation between miR-155 and the diagnosis and prognosis of lung cancer, but results of these researches were still controversial due to insufficient ...

    Authors: Chuchu Shao, Fengming Yang, Zhiqiang Qin, Xinming Jing, Yongqian Shu and Hua Shen
    Citation: BMC Cancer 2019 19:1103
    Content type: Research article Published on:

  37. Idiopathic pulmonary fibrosis (IPF) is the most common type of interstitial pneumonia. Lung cancer, mainly non-small cell lung cancer (NSCLC), is a complication of idiopathic pulmonary fibrosis. IPF is also an...

    Authors: Wenxin Kou, Bo Li, Yeifei Shi, Yifan Zhao, Qing Yu, Jianhui Zhuang, Yawei Xu and Wenhui Peng
    Citation: BMC Cancer 2022 22:110
    Content type: Research Published on:

  38. Although numerous studies have reported the prognostic value of the lung immune prognostic index (LIPI) in non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs), the prog...

    Authors: Yusheng Guo, Yao Pan, Jiayu Wan, Bingxin Gong, Yi Li, Xuefeng Kan and Chuansheng Zheng
    Citation: BMC Cancer 2024 24:523
    Content type: Systematic Review Published on:

  39. Non-small-cell lung cancer (NSCLC) is characterized by abnormalities of numerous signaling proteins that play pivotal roles in cancer development and progression. Many of these proteins have been reported to b...

    Authors: Bao-Feng Jin, Fan Yang, Xiao-Min Ying, Lin Gong, Shuo-Feng Hu, Qing Zhao, Yi-Da Liao, Ke-Zhong Chen, Teng Li, Yan-Hong Tai, Yuan Cao, Xiao Li, Yan Huang, Xiao-Yan Zhan, Xuan-He Qin, Jin Wu…
    Citation: BMC Cancer 2018 18:259
    Content type: Research article Published on:

  41. The prognosis of lung cancer was found to be associated with a series of biomarkers related to the tumor immune microenvironment (TIME), which can modulate the biological behaviors and consequent outcomes of l...

    Authors: Dantong Sun, Lu Tian, Tiantian Bian, Han Zhao, Junyan Tao, Lizong Feng, Qiaoling Liu and Helei Hou
    Citation: BMC Cancer 2020 20:910
    Content type: Research article Published on:

  42. Interstitial lung diseases induced by anticancer agents (ILD-AA) are rare adverse effects of anticancer therapy. However, prognostic biomarkers for ILD-AA have not been identified in patients with advanced lun...

    Authors: Kota Nakamura, Motoyasu Kato, Takehito Shukuya, Keita Mori, Yasuhito Sekimoto, Hiroaki Ihara, Ryota Kanemaru, Ryo Ko, Rina Shibayama, Ken Tajima, Ryo Koyama, Naoko Shimada, Osamu Nagashima, Fumiyuki Takahashi, Shinichi Sasaki and Kazuhisa Takahashi
    Citation: BMC Cancer 2017 17:302
    Content type: Research article Published on:

  43. There is a lack of useful diagnostic tools to identify EGFR mutated NSCLC patients with long-term survival. This study develops a prognostic model using real world data to assist clinicians to predict survival...

    Authors: Lourdes Gutiérrez, Ana Royuela, Enric Carcereny, Rafael López-Castro, Delvys Rodríguez-Abreu, Bartomeu Massuti, José Luis González-Larriba, Rosario García-Campelo, Joaquim Bosch-Barrera, María Guirado, Carlos Camps, Manuel Dómine, Reyes Bernabé, Joaquín Casal, Juana Oramas, Ana Laura Ortega…
    Citation: BMC Cancer 2021 21:977
    Content type: Research Published on:

  44. The prognosis of patients with epidermal growth factor receptor (EGFR) mutant adenocarcinoma of the lung (Mt) and EGFR wild-type adenocarcinoma (Wt) after complete resection of the lung differ; however, the mecha...

    Authors: Tetsuya Isaka, Haruhiko Nakayama, Hiroyuki Ito, Tomoyuki Yokose, Kouzo Yamada and Munetaka Masuda
    Citation: BMC Cancer 2018 18:959
    Content type: Research article Published on:

  45. Systemic inflammation is currently regarded as a hallmark of cancer. This study aimed to accurately clarify the prognostic value of various inflammatory markers in patients with stage IV cancer.

    Authors: He-Yang Zhang, Hai-Lun Xie, Guo-Tian Ruan, Qi Zhang, Yi-Zhong Ge, Xiao-Yue Liu, Meng Tang, Meng-Meng Song, Shi-Qi Lin, Ming Yang, Xiao-Wei Zhang, Hong-Xia Xu, Chun-Hua Song and Han-Ping Shi
    Citation: BMC Cancer 2022 22:1080
    Content type: Research Published on:

  46. Cigarette smoke is associated with the majority of lung cancers: however, 25% of lung cancer patients are non-smokers, and half of all newly diagnosed lung cancer patients are former smokers. Lung tumors exhib...

    Authors: Emily A Vucic, Kelsie L Thu, Larissa A Pikor, Katey SS Enfield, John Yee, John C English, Calum E MacAulay, Stephen Lam, Igor Jurisica and Wan L Lam
    Citation: BMC Cancer 2014 14:778
    Content type: Research article Published on:

  47. Lung cancer is reported to be the leading cause of death in males and females, globally. Increasing evidence highlights the paramount importance of Lactate dehydrogenase D (LDHD) in different types of cancers,...

    Authors: Yu Zhang, Tianyi Zhang, Yingdong Zhao, Hongdi Wu, Qiang Zhen, Suwei Zhu and Shaoshuai Hou
    Citation: BMC Cancer 2023 23:759
    Content type: Research Published on:

  48. Osimertinib, the third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), has become the standard treatment in cases where rebiopsy reveals T790M mutation after the first-line EG...

    Authors: Takuma Imakita, Hirotaka Matsumoto, Katsuya Hirano, Toshiyuki Morisawa, Azusa Sakurai and Yuki Kataoka
    Citation: BMC Cancer 2019 19:105
    Content type: Research article Published on:

  50. PH domain Leucine-rich-repeats protein phosphatase (PHLPP) is a novel family of Ser/Thr protein dephosphatases that play a critical role in maintaining the balance in cell signaling. PHLPP negatively regulates...

    Authors: Dongqing Lv, Haihua Yang, Wei Wang, Youyou Xie, Wei Hu, Minhua Ye and Xiaofeng Chen
    Citation: BMC Cancer 2015 15:687
    Content type: Research article Published on:

Featured videos

View featured videos from across the BMC-series journals

Submit manuscript

Follow

BMC Cancer

ISSN: 1471-2407

Contact us